News

A team of dermatology physician assistants recently reviewed the current and future potential of genomic testing in the realm of dermatology.

The partnership and newly-established center will develop dermatological research and delve into skin aging, skin allergies, and inflammatory or eczematous conditions.

Researchers explored the efficacy of a multistep treatment strategy in a younger patient population.

The conference's course directors give a sneak peek of what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.

The submission deadline for this year’s awards and grants is Friday, March 15, 2024. Award recipients will be notified in June 2024, and the grant period for all awards is 1 year beginning on July 1, 2024.

Investigators highlighted the importance of considering household second hand smoke exposure when evaluating adolescents with AD.

The Technology Breakthrough designation will enable health care providers to access exclusive pricing and terms for the solution in pediatric burn care.

Keep up with the latest headlines in dermatology from the past week, including the role of the US in hosting more than half of the world's skin cancer-related trials, new AAD guidelines for acne, and more.

Today is Women Physicians Day. We are celebrating women on our board who make positive strides in dermatology and strive to advance patient care.

ICYMI, this week we had news about VENT-03's potential as a small molecule therapeutic in dermatology, a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum, and more.

Less than 60% of patients taking systemic medications for skin diseases underwent all recommended bloodwork, a study found.

Compared with cartridge razors, safety razors demonstrated a lower incidence of erythema.

Although new equipment can enhance the capabilities and profitability of a dermatology practice, the decision to make such an investment is a significant one.

The guidelines update the American Academy of Dermatology’s 2016 recommendations for acne management in adults, adolescents, and children aged 9 and older.

In a review of relevant research, investigators found that in many aspects, telemedicine services were as effective as in-office care visits for AD.

Researchers have identified an epigenetic pathway involved in resistance to mitogen-activated protein kinase inhibitors, pointing the way to better patient treatment for resistant melanomas.

People with vitiligo in the US face burdensome health care expenses, including expenses seemingly unrelated to the condition, according to 1 study.

Researchers in China reviewed topical modalities, minoxidil solutions, tofacitinib, and microneedling for pediatric AA.

LC-OCT demonstrated higher sensitivity and negative predictive value compared to other methods of diagnosis and detection.

Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.

An OTC moisturizer was found to improve skin ceramide levels in patients with eczema-prone skin.

A new report looking at melanoma in Black patients adds much-needed clinical insights.

Ablon’s session highlights include best practices for hair restoration.

Dermatology Times is recapping our top expert interviews from the month of January.

The 3-year partnership and collaboration will employ the use of generative artificial intelligence and analytics technologies.

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Learn more about the in-depth topics covered in the January 2024 print issue of Dermatology Times.

Positive results in preclinical animal trials of DPT0218 may lead to advances in clinical treatment of autoimmune diseases.

People with vitiligo face a higher risk of retinal detachment, according to a study in Taiwan.

Functional magnetic resonance imaging response was utilized to test motor, somatosensory association cortex, perception, and sensory integration processing in a recent study.